You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Incentives for orphan drug research and development in the United States
|
---|---|
Published in |
Orphanet Journal of Rare Diseases, December 2008
|
DOI | 10.1186/1750-1172-3-33 |
Pubmed ID | |
Authors |
Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio, Sheryl L Szeinbach, Jay Visaria |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 189 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 3 | 2% |
Germany | 2 | 1% |
Netherlands | 1 | <1% |
Portugal | 1 | <1% |
France | 1 | <1% |
South Africa | 1 | <1% |
Israel | 1 | <1% |
Japan | 1 | <1% |
Unknown | 178 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 45 | 24% |
Researcher | 22 | 12% |
Student > Ph. D. Student | 20 | 11% |
Student > Bachelor | 18 | 10% |
Student > Postgraduate | 13 | 7% |
Other | 34 | 18% |
Unknown | 37 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 37 | 20% |
Pharmacology, Toxicology and Pharmaceutical Science | 21 | 11% |
Business, Management and Accounting | 15 | 8% |
Biochemistry, Genetics and Molecular Biology | 13 | 7% |
Agricultural and Biological Sciences | 13 | 7% |
Other | 46 | 24% |
Unknown | 44 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2023.
All research outputs
#1,047,982
of 23,746,606 outputs
Outputs from Orphanet Journal of Rare Diseases
#106
of 2,743 outputs
Outputs of similar age
#3,727
of 171,548 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#1
of 7 outputs
Altmetric has tracked 23,746,606 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,743 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,548 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them